Om

Apimeds Pharmaceuticals US Inc. is a clinical-stage biopharmaceutical company focused on developing Apitox, a purified bee venom-based therapeutic candidate delivered intradermally. The company is primarily working on treatments for inflammation and pain management, with an emphasis on knee osteoarthritis and, to a lesser extent, multiple sclerosis. Its current business centers on advancing this non-narcotic drug candidate through clinical development and related pharmaceutical activities. Apimeds Pharmaceuticals US Inc. also operates as part of a broader biopharmaceutical platform that includes research, development, and potential commercialization capabilities. Headquartered in Matawan, New Jersey, the company is positioned within the specialty drug manufacturing and biotechnology markets, where its work targets high-need conditions in musculoskeletal and inflammatory care.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I APIMEDS PHARMACEUTICALS US MED ENDAVU: Køb Apimeds Pharmaceuticals US ($APUS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Apimeds Pharmaceuticals US, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.